Marfloquin is a marbofloxacin-based antibiotic indicated for the treatment of multiple infectious diseases in cats and dogs, presented as a palatable tablet for daily administration.
Virbac has introduced Marfloquin, a marbofloxacin-based antibiotic indicated for the treatment of multiple infectious diseases in cats and dogs.
Presented as a palatable, divisible tablet for once daily administration, this new product is is available in three tablet strengths:
- 5 mg for cats and small dogs
- 20 mg for medium sized dogs
- 80 mg for large dogs
Virbac companion animal marketing manager Simon Boulton said: “Marbofloxacin is valued by practices for its efficacy in treating a wide range of skin, soft tissue, urinary tract and respiratory tract infections. The launch of Marfloquin gives them a cost-effective alternative and strengthens our existing antibiotic range.”
- For more information vets are advised to contact their territory manager or call Virbac on 01359 243243.